Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.
作者信息
Moschini Marco, Salonia Andrea, Briganti Alberto, Montorsi Francesco
机构信息
Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
出版信息
Eur Urol. 2023 Oct;84(4):439-440. doi: 10.1016/j.eururo.2023.03.010. Epub 2023 Mar 25.
PMID:36967362
Abstract
摘要
相似文献
1
Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.回复：新辅助膀胱内丝裂霉素-C治疗对非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术前即刻的临床疗效：一项前瞻性随机II期研究的初步结果
Eur Urol. 2023 Oct;84(4):439-440. doi: 10.1016/j.eururo.2023.03.010. Epub 2023 Mar 25.
2
Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study. Letter.新辅助膀胱内丝裂霉素-C疗法在非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术前即刻的临床疗效：一项前瞻性、随机II期研究的初步结果。信函
J Urol. 2023 May;209(5):845-846. doi: 10.1097/JU.0000000000003407. Epub 2023 Mar 9.
3
Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.新辅助膀胱内注射丝裂霉素C治疗对非肌层浸润性膀胱癌患者经尿道膀胱肿瘤切除术前即刻的临床疗效：一项前瞻性、随机II期研究的初步结果
J Urol. 2023 Jan;209(1):131-139. doi: 10.1097/JU.0000000000003002. Epub 2022 Oct 12.
4
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).UGN-102 ± 经尿道膀胱肿瘤切除术与单纯经尿道膀胱肿瘤切除术治疗低级别中危非肌肉浸润性膀胱癌的随机、对照、3 期试验（ATLAS）。
J Urol. 2023 Oct;210(4):619-629. doi: 10.1097/JU.0000000000003645. Epub 2023 Aug 7.
5
Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.回复：DaBlaCa - 13研究：丝裂霉素短期强化化疗切除术治疗非肌层浸润性膀胱癌的肿瘤学结局：一项随机对照试验的主要结局
Eur Urol. 2023 Nov;84(5):512-513. doi: 10.1016/j.eururo.2023.05.028. Epub 2023 Jun 1.
6
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.电渗滴注丝裂霉素即刻经尿道膀胱肿瘤切除术治疗原发性非肌层浸润性膀胱尿路上皮癌患者：一项随机对照试验。
Lancet Oncol. 2011 Sep;12(9):871-9. doi: 10.1016/S1470-2045(11)70190-5. Epub 2011 Aug 8.
7
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.经尿道治疗非肌肉浸润性膀胱癌：系统评价和荟萃分析。
J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.
8
Safety and Efficacy of Immediate Hyperthermic Intravesical Chemotherapy Following Transurethral Resection of Bladder Tumour (I-HIVEC).经尿道膀胱肿瘤切除术后即刻热灌注膀胱化疗（I-HIVEC）的安全性和有效性
Eur Urol Oncol. 2024 Dec;7(6):1171-1174. doi: 10.1016/j.euo.2024.05.006. Epub 2024 May 27.
9
Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study.新辅助短期密集膀胱内丝裂霉素 C 方案与每周方案治疗低级别复发性非肌肉浸润性膀胱癌的比较：一项随机 2 期研究的初步结果。
Eur Urol. 2012 Nov;62(5):797-802. doi: 10.1016/j.eururo.2012.05.032. Epub 2012 May 18.
10
Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.前瞻性随机临床试验：六氨基己酸光动力辅助经尿道膀胱肿瘤切除术（TURBT）联合单次膀胱内丝裂霉素 C 治疗与传统白光 TURBT 联合丝裂霉素 C 治疗新诊断的非肌层浸润性膀胱癌。
BJU Int. 2013 Dec;112(8):1096-104. doi: 10.1111/bju.12355.
Zotero 插件